PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer
Sanofi
Yoon-Koo Kang; Jeong Hwan Yook; Young-Kyu Park; Jong Seok Lee; Young-Woo Kim; Jin Young Kim; Min-Hee Ryu; Sun Young Rha; Ik Joo Chung; In-Ho Kim; Sang Cheul Oh; Young Soo Park; Taeil Son; Mi Ran Jung; Mi Hwa Heo; Hark Kyun Kim; ChoHyun Park; Chang Hak Yoo; Jin-Hyuk Choi; Dae Young Zang; You Jin Jang; Ji Young Sul; Jong Gwang Kim; Beom Su Kim; Seung-Hoon Beom; Sang Hee Cho; Seung Wan Ryu; Myeong-Cherl Kook; Baek-Yeol Ryoo; Hyun Ki Kim; Moon-Won Yoo; Nam Su Lee; Sang Ho Lee; Gyunji Kim; YeonJu Lee; Jee Hyun Lee; Sung Hoon Noh